89bio, Inc.
ETNB
$7.78
$0.1351.77%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/17/2025
-
MarketBeat
5/16/2025
-
Ticker Report
5/16/2025
-
Tickeron - Stocks
5/15/2025
-
MarketBeat
5/14/2025
-
MarketBeat
5/14/2025
-
Tickeron - Stocks
5/13/2025
-
Insider Monkey
5/13/2025
-
Yahoo! Finance: News
5/13/2025
-
Ticker Report
5/13/2025
-
Tickeron - Stocks
5/12/2025
-
Insider Monkey
5/12/2025
-
MarketBeat
5/10/2025
-
Tickeron - Stocks
5/9/2025
-
GuruFocus
5/9/2025
-
GuruFocus
5/9/2025
-
Globe Newswire
5/9/2025
-
MarketBeat
5/9/2025
-
Tickeron - Stocks
5/8/2025
-
MarketBeat
5/8/2025
-
Tickeron - Technical Analysis
5/7/2025
-
Tickeron - Stocks
5/6/2025
-
GuruFocus
5/6/2025
-
Globe Newswire
5/6/2025
-
MarketBeat
5/6/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, May 2, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
415 432 9270
Address
655 Montgomery Street
San Francisco, CA 94111
San Francisco, CA 94111
Country
Year Founded
Business Description
Sector
89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product...
more